Blog
American Liver Foundation (ALF) will bring together patients, caregivers, and family members affected by liver disease from across the country for the Liver Life Advocacy Summit in Washington, D.C., on Tuesday, April 29 and 30 to champion ALF’s 2025 legislative priorities.
ALF anuncia el primer registro de pacientes en español para todo tipo de enfermedades hepáticas para ayudar a garantizar que las necesidades y experiencias de la comunidad hispana/latina se incorporen a los datos que pueden ayudar a conducir a futuros tratamientos y curas para la enfermedad hepática.
ALF announces the first-ever Spanish-language patient registry for all types of liver diseases to help ensure that the needs and experiences of the Hispanic/Latino community will be incorporated into the data that may help lead to future treatments and cures for liver disease.
Unleash your inner foodie and experience a distinct evening of dining all for a good cause. Funds raised benefit the 100 million Americans affected by liver disease through resources, education and support services and help advance our advocacy efforts on Capitol Hill and liver disease research.
American Liver Foundation (ALF) is proud to announce a new living donor network to connect those wishing to donate part of their liver with transplant centers to help patients in need.
We are proud to once again be a member of the 129th Boston Marathon® presented by Bank of America which takes place on Monday, April 21, 2025, at Hopkinton to Boston.
The American Liver Foundation (ALF)) is hosting its annual Liver Life Walk for 2025 at 17 in-person locations across the country.
ALF mourns the tragic loss of Josh Levitsky, MD, MS, FAST, FAASLD, a highly respected, devoted and patient-centric leader in the field of liver transplantation.
American Liver Foundation (ALF) is thrilled to announce the recipients of its prestigious 2024 Liver Scholar and Postdoctoral Research Fellowship Awards. […]
American Liver Foundation (ALF) and the U.S. Department of Veterans Affairs (VA) and Veteran Health Administration (VHA) are excited to announce a partnership to help Veterans who are either at risk or living with liver disease.
American Liver Foundation applauds the Biden Administration for its proposed rule change to expand Medicare and Medicaid coverage for FDA-approved anti-obesity medications.
American Liver Foundation (ALF) is thrilled to announce that Jacquelyn J. Maher, MD, is the winner of its 2024 Distinguished Scientific Achievement Award (DSAA).